Natural compounds and retinal ganglion cell neuroprotection
- PMID: 26497795
- DOI: 10.1016/bs.pbr.2015.05.004
Natural compounds and retinal ganglion cell neuroprotection
Abstract
Glaucoma, the second leading cause of blindness in the world, is a chronic optic neuropathy often associated with increased intraocular pressure and characterized by progressive retinal ganglion cell (RGC) axons degeneration and death leading to typical optic nerve head damage and distinctive visual field defects. Although the pathogenesis of glaucoma is still largely unknown, it is hypothesized that RCGs become damaged through various insults/mechanisms, including ischemia, oxidative stress, excitotoxicity, defective axonal transport, trophic factor withdrawal, and neuroinflammation. In this review, we summarize the potential benefits of several natural compounds for RGCs neuroprotection.
Keywords: Glaucoma; Natural compounds; Neuroprotection; Retinal ganglion cells.
© 2015 Elsevier B.V. All rights reserved.
Similar articles
-
Functional analysis of mesencephalic astrocyte-derived neurotrophic factor in retinal ganglion cells under oxidative stress.Cell Biochem Funct. 2021 Jan;39(1):98-106. doi: 10.1002/cbf.3567. Epub 2020 Jul 1. Cell Biochem Funct. 2021. PMID: 32613670
-
Risk Factors for Retinal Ganglion Cell Distress in Glaucoma and Neuroprotective Potential Intervention.Int J Mol Sci. 2021 Jul 27;22(15):7994. doi: 10.3390/ijms22157994. Int J Mol Sci. 2021. PMID: 34360760 Free PMC article. Review.
-
Autophagy dysregulation and the fate of retinal ganglion cells in glaucomatous optic neuropathy.Prog Brain Res. 2015;220:87-105. doi: 10.1016/bs.pbr.2015.04.009. Epub 2015 Jul 2. Prog Brain Res. 2015. PMID: 26497786 Review.
-
Assessment of retinal ganglion cell damage in glaucomatous optic neuropathy: Axon transport, injury and soma loss.Exp Eye Res. 2015 Dec;141:111-24. doi: 10.1016/j.exer.2015.06.006. Epub 2015 Jun 9. Exp Eye Res. 2015. PMID: 26070986 Review.
-
Gene therapy for retinal ganglion cell neuroprotection in glaucoma.Gene Ther. 2012 Feb;19(2):127-36. doi: 10.1038/gt.2011.142. Epub 2011 Oct 6. Gene Ther. 2012. PMID: 21975466 Review.
Cited by
-
Novel Drug Delivery Systems Fighting Glaucoma: Formulation Obstacles and Solutions.Pharmaceutics. 2020 Dec 26;13(1):28. doi: 10.3390/pharmaceutics13010028. Pharmaceutics. 2020. PMID: 33375224 Free PMC article. Review.
-
In Vivo Evaluation of PAX6 Overexpression and NMDA Cytotoxicity to Stimulate Proliferation in the Mouse Retina.Sci Rep. 2018 Dec 7;8(1):17700. doi: 10.1038/s41598-018-35884-5. Sci Rep. 2018. PMID: 30531887 Free PMC article.
-
Wolfberry genomes and the evolution of Lycium (Solanaceae).Commun Biol. 2021 Jun 3;4(1):671. doi: 10.1038/s42003-021-02152-8. Commun Biol. 2021. PMID: 34083720 Free PMC article.
-
Anti-inflammatory Effect of Curcumin, Homotaurine, and Vitamin D3 on Human Vitreous in Patients With Diabetic Retinopathy.Front Neurol. 2021 Feb 5;11:592274. doi: 10.3389/fneur.2020.592274. eCollection 2020. Front Neurol. 2021. PMID: 33633656 Free PMC article.
-
Using Computational Drug-Gene Analysis to Identify Novel Therapeutic Candidates for Retinal Neuroprotection.Int J Mol Sci. 2022 Oct 21;23(20):12648. doi: 10.3390/ijms232012648. Int J Mol Sci. 2022. PMID: 36293505 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical